Literature DB >> 18354759

Ulcerative colitis and Sweet's syndrome: a case report and review of the literature.

M Ali1, D R Duerksen.   

Abstract

A 47-year-old man with a history of ulcerative colitis on prednisone and azathioprine was admitted to the hospital with a four-day history of fever, skin rash, arthralgias and leukocytosis. A skin biopsy demonstrated neutrophilic infiltration of the dermis that was consistent with Sweet's syndrome. He improved after several days with an increase in his prednisone and azathioprine. Sweet's syndrome is a rare cutaneous manifestation of inflammatory bowel disease, with approximately 40 cases reported in the literature. In a previously reported case of a patient with ulcerative colitis-associated Sweet's syndrome who was on azathioprine at the time of the skin eruption, the azathioprine was stopped, raising the possibility of drug-induced Sweet's syndrome. In the present case, the azathioprine was actually increased with complete resolution of the skin manifestations. This would support the theory that immunosuppressive therapy is the mainstay of therapy for this condition. In conclusion, Sweet's syndrome is a neutrophilic dermatosis that is rarely associated with ulcerative colitis. It may occur while on immunosuppressive therapy and responds to an intensification of immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18354759      PMCID: PMC2662205          DOI: 10.1155/2008/960585

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  14 in total

1.  AN ACUTE FEBRILE NEUTROPHILIC DERMATOSIS.

Authors:  R D SWEET
Journal:  Br J Dermatol       Date:  1964 Aug-Sep       Impact factor: 9.302

2.  Sweet's syndrome and pyoderma gangrenosum associated with ulcerative colitis.

Authors:  E C Benton; D Rutherford; J A Hunter
Journal:  Acta Derm Venereol       Date:  1985       Impact factor: 4.437

3.  Sweet's syndrome in Crohn's disease.

Authors:  D Kemmett; D J Gawkrodger; G Wilson; J A Hunter
Journal:  BMJ       Date:  1988-12-10

4.  Sweet's syndrome: an unusual cutaneous feature of Crohn's disease or ulcerative colitis. The South West Gastroenterology Group.

Authors:  S Travis; N Innes; M G Davies; T Daneshmend; S Hughes
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-07       Impact factor: 2.566

5.  [Sweet's syndrome: report of 5 cases].

Authors:  I Rjeibi; F Zeglaoui; N El Fekih; N Ezzine; B Fazaa; M R Kamoun
Journal:  Rev Med Liege       Date:  2006-12

6.  Neutrophilic pustulosis and ulcerative colitis.

Authors:  J Vázquez; M Almagro; J del Pozo; E Fonseca
Journal:  J Eur Acad Dermatol Venereol       Date:  2003-01       Impact factor: 6.166

Review 7.  Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet's syndrome. Case report and review of literature.

Authors:  O A Paoluzi; P Crispino; A Amantea; R Pica; F Iacopini; A Consolazio; V Di Palma; M Rivera; P Paoluzi
Journal:  Dig Liver Dis       Date:  2004-05       Impact factor: 4.088

Review 8.  Sweet's syndrome revisited: a review of disease concepts.

Authors:  Philip R Cohen; Razelle Kurzrock
Journal:  Int J Dermatol       Date:  2003-10       Impact factor: 2.736

9.  Sweet's syndrome: clinical spectrum and associated conditions.

Authors:  P von den Driesch; R S Gomez; F Kiesewetter; O P Hornstein
Journal:  Cutis       Date:  1989-09

10.  Crohn's disease associated with Sweet's syndrome and Sjögren's syndrome treated with infliximab.

Authors:  Erina N Foster; Khanh K Nguyen; Rafiq A Sheikh; Thomas P Prindiville
Journal:  Clin Dev Immunol       Date:  2005-06
View more
  17 in total

1.  Successful treatment of ulcerative colitis complicated by Sweet's syndrome by corticosteroid therapy and leukocytapheresis.

Authors:  Tomohiro Terai; Mitsushige Sugimoto; Satoshi Osawa; Ken Sugimoto; Takahisa Furuta; Shigeru Kanaoka; Mutsuhiro Ikuma
Journal:  Clin J Gastroenterol       Date:  2011-03-29

Review 2.  Review.

Authors:  Vikas Pabby; Robert Burakoff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-08

3.  Successful treatment of localized pyoderma faciale in a patient with Crohn's disease.

Authors:  Sanam Razeghi; Christian R Halvorson; Anthony A Gaspari; Raymond K Cross
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-08

4.  Oral Sweet's syndrome occurring in ulcerative colitis.

Authors:  Laura Aisling Nestor; Anne-Marie Tobin
Journal:  BMJ Case Rep       Date:  2017-03-15

Review 5.  Skin Manifestations of Inflammatory Bowel Disease.

Authors:  Thomas Greuter; Alexander Navarini; Stephan R Vavricka
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 6.  Current clinical issue of skin lesions in patients with inflammatory bowel disease.

Authors:  Tomoya Iida; Tokimasa Hida; Minoru Matsuura; Hisashi Uhara; Hiroshi Nakase
Journal:  Clin J Gastroenterol       Date:  2019-03-05

Review 7.  Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria.

Authors:  Angelo V Marzano; Rim S Ishak; Simone Saibeni; Carlo Crosti; Pier Luigi Meroni; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

8.  Sweet's syndrome complicating ulcerative colitis: a rare association.

Authors:  Rute Lopes Caçola; Marta Soares; Carla Cardoso; António Furtado
Journal:  BMJ Case Rep       Date:  2016-01-20

Review 9.  A causal association between isotretinoin and inflammatory bowel disease has yet to be established.

Authors:  Seth D Crockett; Ajay Gulati; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2009-10       Impact factor: 10.864

10.  Systematic Review: Sweet Syndrome Associated with Inflammatory Bowel Disease.

Authors:  Joseph Sleiman; Asif A Hitawala; Benjamin Cohen; Katie Falloon; Marian Simonson; Benjamin Click; Urmi Khanna; Anthony P Fernandez; Florian Rieder
Journal:  J Crohns Colitis       Date:  2021-11-08       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.